ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000251003.3	AKT inhibitor VIII	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.042248339	Resistant
ENSG00000251003.3	AKT inhibitor VIII	Lung squamous cell carcinoma	0.002605453	Sensitive